Many Neuronal and Behavioral Impairments in Transgenic Mouse Models of Alzheimer's Disease Are Independent of Caspase Cleavage of the Amyloid Precursor Protein
Julie A. Harris(Allen Institute), Lennart Mucke(Gladstone Institutes), Nino Devidze(Gladstone Institutes), Eliezer Masliah(University of California San Diego), Myo T. Thwin(Yangon Technological University), Iris Lo(Gladstone Institutes), Gui-Qiu Yu(Gladstone Institutes), Dale E. Bredesen(Drug Discovery Laboratory (Norway)), Brian Halabisky(Gladstone Institutes)
Cited by 151
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
|Alzheimer s & Dementia|2012|3.2k
National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
|Acta Neuropathologica|2011|2.9k
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
|Journal of Neuropathology & Experimental Neurology|2012|2.1k